Kadmon Corporation, a biopharmaceutical company, offers products and services for the treatment and management of hepatitis C. Its products include Ribasphere RibaPak (ribavirin, USP) tablets, which help to reduce pill burden while providing patients with treatment that is biologically equivalent to other ribavirin medications; INFERGEN (interferon alfacon-1) to treat chronic hepatitis C in patients 18 years of age or older with compensated liver disease; Ribasphere (ribavirin, USP) tablets and capsules, which are antiviral medications for use in combination with other drugs for the treatment of chronic hepatitis C; and KD020, a reversible tyrosine kinase inhibitor that targets EGFR, HER2, VEGFR 2/3, and Src in autosomal dominant polycystic kidney disease (PKD). The company also provides various services and programs to support patients, prescribers, and pharmacies, including patient assistance programs to provide free medication to patients with limited or no insurance coverage; temporary shipments for patients on current or recent therapy; and nurse support services. In addition, it develops medicines in oncology, infectious diseases, immunology, and neurodegenerative diseases. The company was formerly known as Kadmon Holdings. Kadmon Corporation was incorporated in 2009 and is based in New York, New York with operations in Warrendale, Pennsylvania; and Boston, Massachusetts.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Kadmon Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kadmon Holdings Inc market cap is $581.01M.
What is the 52-week high for Kadmon Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kadmon Holdings Inc 52 week high is $5.50 as of April 18, 2024.
What is the 52-week low for Kadmon Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kadmon Holdings Inc 52 week low is $2.30 as of April 18, 2024.
What was Kadmon Holdings Inc stock price yesterday?
Kadmon Holdings Inc stock price yesterday was $9.50.
What is the PE ratio of Kadmon Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kadmon Holdings Inc’s P/E ratio is -3.63.
What is the Price-to-Book ratio of Kadmon Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kadmon Holdings Inc P/B ratio is 4.8492.
What is the 50-day moving average of Kadmon Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kadmon Holdings Inc 50-day moving average is $4.15.